Holen Sie sich die Stockscreener-App
7.38
1.60%
-0.12
Handel nachbörslich:
7.35
-0.03
-0.41%
Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
10.30%
9.652
|
8.751 | 7.925 | 6.974 | 7.262 |
Operating Expenses
|
29.55%
12.38
|
9.559 | 8.859 | 12.18 | 12.30 |
| Benefits Costs and Expenses |
100.00%
-
|
9.916 | 9.545 | - | - |
| Costs And Expenses |
24.89%
12.38
|
9.916 | 9.545 | 12.18 | 12.30 |
| Operating Income/Loss |
238.12%
-2.732
|
-0.808 | -0.934 | -5.202 | -5.039 |
| Nonoperating Income/Loss |
17.65%
-0.42
|
-0.357 | -0.686 | -0.533 | -0.514 |
| Income/Loss From Continuing Operations Before Tax |
928.50%
9.652
|
-1.165 | -1.62 | 6.974 | -5.553 |
| Income/Loss From Continuing Operations After Tax |
170.56%
-3.152
|
-1.165 | -1.985 | -5.735 | -5.553 |
|
Net Income/Loss
|
170.56%
-3.152
|
-1.165 | -1.985 | -5.735 | -5.553 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.31%
27.66
|
27.58 | -0.077 | 27.37 | 27.30 |
| Diluted Average Shares |
0.31%
27.66
|
27.58 | -0.721 | 27.37 | 27.30 |
| Basic Earnings Per Share |
175.00%
-0.11
|
-0.04 | -0.08 | -0.21 | -0.20 |
| Diluted Earnings Per Share |
175.00%
-0.11
|
-0.04 | -0.08 | -0.21 | -0.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):